TLR3 and COVID-19: Recent studies revealed that patients bearing genetic mutations in TLR3 and TLR7 signaling experienced severe outcomes of coronavirus disease 2019 (COVID-19; Asano et al., 2021; Zhang et al., 2020), suggesting the crucial protective function of TLR3/7 signaling against SARS-CoV-2 infection.